Lilly Exec Talks Insulin Market
Sydney Otomancek2023-12-14T13:21:34-05:00January 18th, 2020|Categories: Featured, Industry News|Tags: diabetes, Eli Lilly, Humalog, Insulin, Lispro, market access|
Pharmalot recently caught up with Mike Mason, head of Eli Lilly's diabetes branch, to discuss the drugmaker's generic alternative to [...]
ICER Releases Final Report on JAK Inhibitors for RA
Sydney Otomancek2023-12-14T13:21:44-05:00January 10th, 2020|Categories: Featured, Industry News|Tags: Eli Lilly, Healtheconomics.com, HEOR, ICER, Institute for Clinical and Economic Review, JAK inhibitors, market access, Pfizer|
The Institute for Clinical and Economic Review (ICER) on Thursday, Jan. 9, released its final report on JAK inhibitors for [...]
Receive essential insights, resources and content direct to your inbox!
Hit subscribe to stay informed!
Advertisement
Latest News
Featured Webinars
Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping
Thursday, May 23, 2024
Sponsor: OM1
Insights from the 2024 Salary Survey Report by HealthEconomics.com
Wednesday, May 1, 2024
Webinar Host: Scientist.com
Beyond Accelerated Approvals: External Control Arms
Wednesday, April 10, 2024
Sponsor: Cardinal Health
Categories
Artificial Intelligence
Careers
Clinical Trials
Cost Effectiveness
Data Analytics & Syndicated Reports
Healthcare Financing
Health Databases
Health Equity
Health Policy
Health Tech Assessment
HEOR
Integrated Evidence Assessment & Planning
Market Access
Medical Affairs
Patient Outcomes & Engagement
Press Release
Pricing & Reimbursement
Real World Data
Real World Evidence
Value Assessment
Value Communication